<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05088005</url>
  </required_header>
  <id_info>
    <org_study_id>CO-new biomarkers</org_study_id>
    <nct_id>NCT05088005</nct_id>
  </id_info>
  <brief_title>Prognostic Biomarkers in CO Poisoning</brief_title>
  <official_title>Prognostic Biomarkers of Mitochondrial and Oxidative Stress in Acute Carbon Monoxide Poisoning: Prospective Hyperbaric Oxygen Therapy Intervention Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wonju Severance Christian Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Research Foundation of Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Wonju Severance Christian Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Mitochondrial and oxidative stress participate in the pathogenic mechanisms of carbon&#xD;
      monoxide (CO)-induced toxicity. Thus, serum indicators of mitochondrial and oxidative stress&#xD;
      could be useful for predicting neurocognitive prognosis of post-CO poisoning. This&#xD;
      prospective observational study of consecutive patients requiring hyperbaric oxygen therapy&#xD;
      (HBO2) for acute CO poisoning measured serum biomarkers of mitochondrial (growth&#xD;
      differentiation factor 15 [GDF15]; fibroblast growth factor 21 [FGF21]) and oxidative&#xD;
      (8-Oxo-2'-deoxyguanosine [8-OHdG] and malondialdehyde [MDA]) stresses at arrival at the&#xD;
      emergency department (0 h), and at 24 h and 7 days after HBO2 completion. We evaluated&#xD;
      neurocognitive outcomes using the Global Deterioration Scale (GDS; favorable [1-3 points] or&#xD;
      poor [4-7 points] outcomes).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mitochondrial and oxidative stress participate in the pathogenic mechanisms of carbon&#xD;
      monoxide (CO)-induced toxicity. Thus, serum indicators of mitochondrial and oxidative stress&#xD;
      could be useful for predicting neurocognitive prognosis of post-CO poisoning.&#xD;
&#xD;
      This prospective observational study of consecutive patients requiring hyperbaric oxygen&#xD;
      therapy (HBO2) for acute CO poisoning measured serum biomarkers of mitochondrial (growth&#xD;
      differentiation factor 15 [GDF15]; fibroblast growth factor 21 [FGF21]) and oxidative&#xD;
      (8-Oxo-2'-deoxyguanosine [8-OHdG] and malondialdehyde [MDA]) stresses at arrival at the&#xD;
      emergency department (0 h), and at 24 h and 7 days after HBO2 completion. We evaluated&#xD;
      neurocognitive outcomes using the Global Deterioration Scale (GDS; favorable [1-3 points] or&#xD;
      poor [4-7 points] outcomes).&#xD;
&#xD;
      Levels of serum mitochondrial (GDF15 and FGF21) and oxidative stress (8-OHdG and MDA)&#xD;
      biomarkers pre- and post-HBO2 were compared, to assess whether HBO2 reduced stress. In&#xD;
      addition, we evaluated whether the blood test results correlated with the patient's&#xD;
      neurocognitive prognosis at 1 month.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Actual">February 28, 2021</completion_date>
  <primary_completion_date type="Actual">January 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes of serum biomarkers between pre-HBO2 and post HBO2</measure>
    <time_frame>At 1 day after HBO2</time_frame>
    <description>Levels of serum mitochondrial (GDF15 and FGF21) and oxidative stress (8-OHdG and MDA) biomarkers pre- and post-HBO2 were compared, to assess whether HBO2 reduced stress.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes of serum biomarkers between pre-HBO2 and post HBO2</measure>
    <time_frame>At 7 days after HBO2</time_frame>
    <description>Levels of serum mitochondrial (GDF15 and FGF21) and oxidative stress (8-OHdG and MDA) biomarkers pre- and post-HBO2 were compared, to assess whether HBO2 reduced stress.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The prediction of poor neurocognitive outcome by serum biomarkers</measure>
    <time_frame>At 1 month after CO exposure</time_frame>
    <description>The prediction of serum biomarkers for the patient's neurocognitive prognosis at 1 month</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">51</enrollment>
  <condition>Carbon Monoxide Poisoning</condition>
  <condition>Hyperbaric Oxygenation</condition>
  <condition>Biomarkers</condition>
  <arm_group>
    <arm_group_label>Acute CO poisoning</arm_group_label>
    <description>A diagnosis of CO poisoning was made according to medical history and carboxyhemoglobin &gt;5% (&gt;10% in smokers).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hyperbaric oxygen therapy</intervention_name>
    <description>Patients with any symptoms and signs were treated with HBO2. During the first HBO2, initial compression was performed to 2.8 atmospheres absolute (ATA) for 45 min, followed by 2.0 ATA for 60 min. If an additional HBO2 was possible within 24 h, then 2.0 ATA was administered for 90 min.</description>
    <arm_group_label>Acute CO poisoning</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        CO poisoned patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  CO poisoned patients&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. age &lt; 19 years&#xD;
&#xD;
          2. a history of metabolic diseases&#xD;
&#xD;
          3. co-ingestion of drugs and alcohol, which may affect the biomarkers&#xD;
&#xD;
          4. discharge from the ED or transfer to another hospital&#xD;
&#xD;
          5. refusal to undergo HBO2&#xD;
&#xD;
          6. refusal to enroll in this study&#xD;
&#xD;
          7. lack of follow-up for assessing neurocognitive outcomes.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Wonju Severance Christian Hospital</name>
      <address>
        <city>Wonju</city>
        <state>Gangwon</state>
        <zip>26426</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 8, 2021</study_first_submitted>
  <study_first_submitted_qc>October 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 21, 2021</study_first_posted>
  <last_update_submitted>October 8, 2021</last_update_submitted>
  <last_update_submitted_qc>October 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wonju Severance Christian Hospital</investigator_affiliation>
    <investigator_full_name>Yong Sung Cha</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Poisoning</mesh_term>
    <mesh_term>Carbon Monoxide Poisoning</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

